LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 20, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	854	794	-	-	-
Enterprise Value	652	578	-	-	-
Last Close Price	30.03	28.87	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Asset Turnover	-	-	-	0.46	-
Quick Ratio	22.64	20.09	3.55	4.68	14.61
Current Ratio	23.09	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-24.47%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-17.76%	-25.64%	-77.17%	-20.07%	-
Return on Capital (ROIC)	-18.96%	-28.47%	-101.31%	-24.01%	-
Buyback Yield / Dilution	-917.91%	-986.27%	79.28%	-1.05%	-

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q